%% This BibTeX bibliography file was created using BibDesk.
%% https://bibdesk.sourceforge.io/

%% Created for Vincent Montero at 2022-10-10 17:22:01 -0400 


%% Saved with string encoding Unicode (UTF-8) 



@article{mathias-2020-nitroimidazooxazoles-antikinetoplastid,
	abstract = {In continuation of our pharmacomodulation work on the nitroimidazooxazole series, we report the synthesis of new 5-substituted 6-nitroimidazooxazole derivatives. Our aim was to evaluate how functionalization of the 5-position of the 6-nitroimidazooxazole scaffold affects antileishmanial and antitrypanosomal in vitro activities. Twenty-one original compounds were synthesized and evaluated for their in vitro antileishmanial (L. donovani) and antitrypanosomal (T. cruzi) properties. Pallado-catalyzed cross-coupling reactions were used to introduce an aryl or ethynyl aryl substituent in 5-position from a 5-brominated-6-nitroimidazooxazole starting product. Unfortunately, the first series of compounds bearing an aryl group in 5-position presented limited in vitro activities against L. donovani and T. cruzi, with IC(50) > 10 μM (vs 0.18 μM and 2.31 μM for the reference drugs amphotericin B and benznidazole respectively). Interestingly, the second series of compounds bearing an ethynyl aryl substituent in 5-position showed more promising, particularly against T. cruzi. Compounds 6a, 6b, 6c, 6g and 6h had better activity than the reference drug benznidazole (0.92 μM ≤ IC(50) ≤ 2.18 μM vs IC(50) = 2.31 μM), whereas the non-functionalized 2-methyl-6-nitro-2,3-dihydroimidazo [2,1-b]oxazole 2 was not active against T. cruzi (IC(50) > 10 μM).},
	address = {Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, 30602, USA.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, 30602, USA; Department of Cellular Biology, University of Georgia, Athens, GA, 30602, USA.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France. Electronic address: patrice.vanelle@univ-amu.fr.},
	author = {Mathias, Fanny and Cohen, Anita and Kabri, Youssef and Negr{\~a}o, N{\'u}ria Waddington and Crozet, Maxime D and Docampo, Roberto and Azas, Nadine and Vanelle, Patrice},
	cois = {Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.},
	copyright = {Copyright {\copyright}2020 Elsevier Masson SAS. All rights reserved.},
	crdt = {2020/02/24 06:00},
	date = {2020 Apr 1},
	date-added = {2022-10-10 17:21:48 -0400},
	date-modified = {2022-10-10 17:22:01 -0400},
	dcom = {20201104},
	dep = {20200214},
	doi = {10.1016/j.ejmech.2020.112146},
	edat = {2020/02/24 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {Imidazo 2,1-b oxazole; Leishmania; Nitroheterocycles; Pallado-catalyzed cross-coupling reaction; Trypanosoma},
	language = {eng},
	lid = {S0223-5234(20)30113-6 {$[$}pii{$]$}; 10.1016/j.ejmech.2020.112146 {$[$}doi{$]$}},
	lr = {20201104},
	mh = {Antiprotozoal Agents/chemical synthesis/chemistry/*pharmacology; Dose-Response Relationship, Drug; Leishmania donovani/*drug effects; Molecular Structure; Nitroimidazoles/chemical synthesis/chemistry/*pharmacology; Oxazoles/chemical synthesis/chemistry/*pharmacology; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma cruzi/*drug effects},
	mhda = {2020/11/05 06:00},
	month = {Apr},
	oto = {NOTNLM},
	own = {NLM},
	pages = {112146},
	phst = {2019/12/03 00:00 {$[$}received{$]$}; 2020/02/12 00:00 {$[$}revised{$]$}; 2020/02/12 00:00 {$[$}accepted{$]$}; 2020/02/24 06:00 {$[$}pubmed{$]$}; 2020/11/05 06:00 {$[$}medline{$]$}; 2020/02/24 06:00 {$[$}entrez{$]$}},
	pii = {S0223-5234(20)30113-6},
	pl = {France},
	pmid = {32088496},
	pst = {ppublish},
	pt = {Journal Article},
	rn = {0 (Antiprotozoal Agents); 0 (Nitroimidazoles); 0 (Oxazoles)},
	sb = {IM},
	status = {MEDLINE},
	title = {Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents.},
	volume = {191},
	year = {2020},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2020.112146}}

@article{spitz-2020-super-oed,
	abstract = {We report here the intermolecular metal-free addition reaction of functionalized benzyl halides to aldehydes using a super electron donor (SED). The metal-free and mild conditions allowed the formation of 3,4-dihydroisocoumarins and 1,2-diarylethanols with unprecedented functional group tolerance.},
	address = {Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR CNRS 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS 30064, Cedex 05 13385 Marseille, France.},
	auid = {ORCID: 0000-0002-6473-3073; ORCID: 0000-0003-4309-8004},
	author = {Spitz, C{\'e}dric and Matteudi, M{\'e}lanie and Tintori, Guillaume and Broggi, Julie and Terme, Thierry and Vanelle, Patrice},
	crdt = {2020/11/23 12:09},
	date = {2020 Dec 4},
	date-added = {2022-10-10 17:20:56 -0400},
	date-modified = {2022-10-10 17:21:27 -0400},
	dep = {20201123},
	doi = {10.1021/acs.joc.0c02374},
	edat = {2020/11/24 06:00},
	eissn = {1520-6904},
	issn = {0022-3263},
	jcr = {J ORG CHEM},
	jid = {2985193R},
	journal = {J. Org. Chem.},
	jt = {JOURNAL OF ORGANIC CHEMISTRY},
	language = {eng},
	lid = {10.1021/acs.joc.0c02374 {$[$}doi{$]$}},
	lr = {20201204},
	mhda = {2020/11/24 06:01},
	month = {Dec},
	number = {23},
	own = {NLM},
	pages = {15736--15742},
	phst = {2020/11/24 06:00 {$[$}pubmed{$]$}; 2020/11/24 06:01 {$[$}medline{$]$}; 2020/11/23 12:09 {$[$}entrez{$]$}},
	pl = {United States},
	pmid = {33226220},
	pst = {ppublish},
	pt = {Journal Article},
	sb = {IM},
	status = {PubMed-not-MEDLINE},
	title = {Metal-Free Addition of Benzyl Halides to Aldehydes Using Super Electron Donors: Access to 3,4-Dihydroisocoumarins and 1,2-Diarylethanols.},
	volume = {85},
	year = {2020},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1021/acs.joc.0c02374}}

@article{nadji-2015-tdae,
	author = {Nadji-Boukrouche, A{\"\i}da R and Khoumeri, Omar and Terme, Thierry and Liacha, Messaoud and Vanelle, Patrice},
	date-added = {2022-10-10 17:12:58 -0400},
	date-modified = {2022-10-10 17:13:04 -0400},
	eissn = {1420-3049},
	issn = {1420-3049},
	jcr = {MOLECULES},
	journal = {Molecules},
	jt = {MOLECULES},
	number = {1},
	pages = {1262--1276},
	publisher = {Multidisciplinary Digital Publishing Institute},
	title = {TDAE Strategy in the Benzoxazolone Series: Synthesis and Reactivity of a New Benzoxazolinonic Anion},
	volume = {20},
	year = {2015},
	bdsk-file-1 = {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}}

@article{terme-2008-tdae,
	abstract = {Research, developed at the Laboratory of Organic Pharmaceutical Chemistry of the School of Pharmacy, UMR-CNRS 6517, is centred on the synthesis of novel therapeutic compounds using monoelectronic transfer reactions. Tetrakis(dimethylamino)ethylene (TDAE) is a powerful electron donor which has the specific property of activating the carbon-halogen bond leading to the formation of a stable electrophilic radical and a stable neutrophilic anion. Since 2002, our team has developed a program using monoelectronic transfer reactions initiated by TDAE of nitroaromatic, nitroheterocyclic and quinonic bioreducible alkylating agents. The goal is to synthesize new therapeutic compounds for use as anti-infectious agents, anticancer agents, and agents active on the central nervous system. In this context, we present the first pharmacochemical tools obtained with this strategy during reactions between diverse electrophilic compounds (aldehydes, ketones, alpha-keto-esters, ketomalonates, alpha-ketolactames, ...) and benzylic anions formed in situ by the action of TDAE. We illustrate the usefulness of this strategy by describing the preparation of new compounds of biological interest and the associated pharmacomodulation work.},
	address = {UMR-CNRS 6517, laboratoire de chimie organique pharmaceutique, facult{\'e}de pharmacie, universit{\'e} de M{\'e}diterran{\'e}e, 27, boulevard Jean-Moulin, 13385 Marseille cedex 5, France.},
	author = {Terme, T and Vanelle, P},
	crdt = {2008/06/24 09:00},
	date = {2008 Mar},
	date-added = {2022-10-10 17:00:57 -0400},
	date-modified = {2022-10-10 17:01:04 -0400},
	dcom = {20080903},
	dep = {20080527},
	doi = {10.1016/j.pharma.2008.03.001},
	edat = {2008/06/24 09:00},
	eissn = {0003-4509},
	issn = {0003-4509},
	jcr = {ANN PHARM FR},
	jid = {2985176R},
	journal = {Ann. Pharm. Fr.},
	jt = {ANNALES PHARMACEUTIQUES FRANCAISES},
	language = {fre},
	lid = {10.1016/j.pharma.2008.03.001 {$[$}doi{$]$}},
	lr = {20080623},
	mh = {Alkylating Agents/chemical synthesis/chemistry; Aniline Compounds/*chemistry; Anti-Infective Agents/chemical synthesis/chemistry; Antineoplastic Agents, Alkylating/chemical synthesis/chemistry; Central Nervous System Agents/chemical synthesis/chemistry; Electrons; Indicators and Reagents; Pharmaceutical Preparations/*chemical synthesis},
	mhda = {2008/09/04 09:00},
	month = {Mar},
	number = {2},
	own = {NLM},
	pages = {77--84},
	phst = {2008/01/10 00:00 {$[$}received{$]$}; 2008/03/26 00:00 {$[$}accepted{$]$}; 2008/06/24 09:00 {$[$}pubmed{$]$}; 2008/09/04 09:00 {$[$}medline{$]$}; 2008/06/24 09:00 {$[$}entrez{$]$}},
	pii = {S0003-4509(08)00026-6},
	pl = {France},
	pmid = {18570903},
	pst = {ppublish},
	pt = {English Abstract; Journal Article},
	rn = {0 (Alkylating Agents); 0 (Aniline Compounds); 0 (Anti-Infective Agents); 0 (Antineoplastic Agents, Alkylating); 0 (Central Nervous System Agents); 0 (Indicators and Reagents); 0 (Pharmaceutical Preparations); 86669-21-8 (tetrakis(4-(dimethylamino)phenyl)ethylene)},
	sb = {IM},
	status = {MEDLINE},
	title = {TDAE strategy applied to drug-candidate synthesis.},
	tt = {Strat{\'e}gie TDAE appliqu{\'e}e {\`a}la synth{\`e}se de candidats-m{\'e}dicaments.},
	volume = {66},
	year = {2008},
	bdsk-file-1 = {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},
	bdsk-file-2 = {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},
	bdsk-file-3 = {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},
	bdsk-file-4 = {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},
	bdsk-file-5 = {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},
	bdsk-file-6 = {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},
	bdsk-file-7 = {YnBsaXN0MDDSAQIDBFxyZWxhdGl2ZVBhdGhZYWxpYXNEYXRhXxAwLi4vYmlibGlvLzIwMTZYaWFfWEstNDY5X3BlcHRpZGVzX2FuYWxvZ3Vlcy5uYmliTxECKgAAAAACKgACAAAMTWFjaW50b3NoIEhEAAAAAAAAAAAAAAAAAAAAAAAAAEJEAAH/////HzIwMTZYaWFfWEstNDY5X3BlI0ZGRkZGRkZGLm5iaWIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP////8AAAAAAAAAAAAAAAAAAQACAAAKIGN1AAAAAAAAAAAAAAAAAAZiaWJsaW8AAgCCLzpVc2Vyczp2aW5jZW50bW9udGVybzpMaWJyYXJ5Ok1vYmlsZSBEb2N1bWVudHM6Y29tfmFwcGxlfkNsb3VkRG9jczowMl93b3JrOnJlc2VhcmNoOmJpYmxpbzoyMDE2WGlhX1hLLTQ2OV9wZXB0aWRlc19hbmFsb2d1ZXMubmJpYgAOAE4AJgAyADAAMQA2AFgAaQBhAF8AWABLAC0ANAA2ADkAXwBwAGUAcAB0AGkAZABlAHMAXwBhAG4AYQBsAG8AZwB1AGUAcwAuAG4AYgBpAGIADwAaAAwATQBhAGMAaQBuAHQAbwBzAGgAIABIAEQAEgCAVXNlcnMvdmluY2VudG1vbnRlcm8vTGlicmFyeS9Nb2JpbGUgRG9jdW1lbnRzL2NvbX5hcHBsZX5DbG91ZERvY3MvMDJfd29yay9yZXNlYXJjaC9iaWJsaW8vMjAxNlhpYV9YSy00NjlfcGVwdGlkZXNfYW5hbG9ndWVzLm5iaWIAEwABLwAAFQACABX//wAAAAgADQAaACQAVwAAAAAAAAIBAAAAAAAAAAUAAAAAAAAAAAAAAAAAAAKF},
	bdsk-url-1 = {https://doi.org/10.1016/j.pharma.2008.03.001}}

@article{roche-2014-dimethoxybenzene-rhinovirus,
	abstract = {Human rhinoviruses are a common cause of respiratory infections, and thus constitute an important target for medicinal chemistry. Still, no drug has been approved for clinical use. We report herein the discovery of dibenzenic derivatives with potent and specific in vitro anti-rhinoviral 14 activity. A total of 99 structural analogues were synthesized by an original synthesis method, i.e. through one organic agent Tetrakis(DimethylAmino)Ethylene (TDAE) and a structure-activity relationship was established. It was shown that 4,5-dimethoxy scaffold and the presence of a C-4 substituted aromatic moiety were necessary to the in vitro activity of these original agents. However, modifications on liker were not convincing. The benzonitrile derivative 23 was identified as the most potent and selective inhibitor of rhinovirus replication in these series (EC₅₀ of 2 $\pm$ 0.5 μM, CC₅₀ of 184 μM, selectivity index of 92).},
	address = {Aix-Marseille Univ, Institut de Chimie Radicalaire, UMR 7273, CNRS 27, Boulevard Jean Moulin Marseille, France.; Laboratory of Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.; Aix-Marseille Univ, Institut de Chimie Radicalaire, UMR 7273, CNRS 27, Boulevard Jean Moulin Marseille, France.; Laboratory of Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.; Laboratory of Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. Electronic address: johan.neyts@rega.kuleuven.be.; Aix-Marseille Univ, Institut de Chimie Radicalaire, UMR 7273, CNRS 27, Boulevard Jean Moulin Marseille, France.; Laboratory of Virology and Experimental Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.; Aix-Marseille Univ, Institut de Chimie Radicalaire, UMR 7273, CNRS 27, Boulevard Jean Moulin Marseille, France. Electronic address: patrice.vanelle@univ-amu.fr.},
	author = {Roche, Manon and Lacroix, C{\'e}line and Khoumeri, Omar and Franco, David and Neyts, Johan and Terme, Thierry and Leyssen, Pieter and Vanelle, Patrice},
	copyright = {Copyright {\copyright}2014 Elsevier Masson SAS. All rights reserved.},
	crdt = {2014/03/08 06:00},
	date = {2014 Apr 9},
	date-added = {2022-10-10 16:59:05 -0400},
	date-modified = {2022-10-10 17:00:44 -0400},
	dcom = {20141203},
	dep = {20140217},
	doi = {10.1016/j.ejmech.2014.01.034},
	edat = {2014/03/08 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {4,5-Dimethoxybenzenes; Antiviral activity; Human rhinovirus 14; Tetrakis(DimethylAmino)Ethylene},
	language = {eng},
	lid = {S0223-5234(14)00080-4 {$[$}pii{$]$}; 10.1016/j.ejmech.2014.01.034 {$[$}doi{$]$}},
	lr = {20140321},
	mh = {Antiviral Agents/*chemical synthesis/chemistry/*therapeutic use; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Nitriles/*chemical synthesis/chemistry/*therapeutic use; Phenylethyl Alcohol/*analogs \& derivatives/chemical synthesis/chemistry/therapeutic use; Picornaviridae Infections/*drug therapy; Rhinovirus/*drug effects; Structure-Activity Relationship},
	mhda = {2014/12/15 06:00},
	month = {Apr},
	oto = {NOTNLM},
	own = {NLM},
	pages = {445--459},
	phst = {2013/11/20 00:00 {$[$}received{$]$}; 2014/01/14 00:00 {$[$}revised{$]$}; 2014/01/18 00:00 {$[$}accepted{$]$}; 2014/03/08 06:00 {$[$}entrez{$]$}; 2014/03/08 06:00 {$[$}pubmed{$]$}; 2014/12/15 06:00 {$[$}medline{$]$}},
	pii = {S0223-5234(14)00080-4},
	pl = {France},
	pmid = {24602790},
	pst = {ppublish},
	pt = {Journal Article; Research Support, Non-U.S. Gov't},
	rn = {0 (4-(2-(4,5-dimethoxy-2-nitrophenyl)-1-hydroxyethyl)benzonitrile); 0 (Antiviral Agents); 0 (Nitriles); ML9LGA7468 (Phenylethyl Alcohol)},
	sb = {IM},
	status = {MEDLINE},
	title = {Synthesis, biological activity and structure-activity relationship of 4,5-dimethoxybenzene derivatives inhibitor of rhinovirus 14 infection.},
	volume = {76},
	year = {2014},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2014.01.034}}

@article{paoli-2020-nitroimidazopyridine-trypanosoma,
	abstract = {To study the antikinetoplastid 3-nitroimidazo{$[$}1,2-a{$]$}pyridine pharmacophore, a structure-activity relationship study was conducted through the synthesis of 26 original derivatives and their in vitro evaluation on both Leishmania spp and Trypanosoma brucei brucei. This SAR study showed that the antitrypanosomal pharmacophore was less restrictive than the antileishmanial one and highlighted positions 2, 6 and 8 of the imidazopyridine ring as key modulation points. None of the synthesized compounds allowed improvement in antileishmanial activity, compared to previous hit molecules in the series. Nevertheless, compound 8, the best antitrypanosomal molecule in this series (EC(50) = 17 nM, SI = 2650 & E$\,^{\circ}$ = -0.6 V), was not only more active than all reference drugs and previous hit molecules in the series but also displayed improved aqueous solubility and better in vitro pharmacokinetic characteristics: good microsomal stability (T(1/2) > 40 min), moderate albumin binding (77%) and moderate permeability across the blood brain barrier according to a PAMPA assay. Moreover, both micronucleus and comet assays showed that nitroaromatic molecule 8 was not genotoxic in vitro. It was evidenced that bioactivation of molecule 8 was operated by T. b. brucei type 1 nitroreductase, in the same manner as fexinidazole. Finally, a mouse pharmacokinetic study showed that 8 displayed good systemic exposure after both single and repeated oral administrations at 100 mg/kg (NOAEL) and satisfying plasmatic half-life (T(1/2) = 7.7 h). Thus, molecule 8 appears as a good candidate for initiating a hit to lead drug discovery program.},
	address = {Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Universit{\'e}de Limoges, UMR Inserm 1094, Neuro{\'e}pid{\'e}miologie Tropicale, Facult{\'e}de Pharmacie, 2 Rue Du Dr Marcland, 87025, Limoges, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Universit{\'e}de Limoges, BISCEm, US 042 INSERM - UMS 2015 CNRS, Mass Spectrometry Platform, CBRS, 2 Rue Du Pr. Descottes, F-87025, Limoges, France.; Aix Marseille Univ, IHU M{\'e}diterran{\'e}e Infection, UMR VITROME - Tropical Eukaryotic Pathogens, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; LCC-CNRS Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; UMR 152 PHARMA-DEV, Universit{\'e}de Toulouse, IRD, UPS, Toulouse, France.; LCC-CNRS Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; LCC-CNRS Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; UMR 152 PHARMA-DEV, Universit{\'e}de Toulouse, IRD, UPS, Toulouse, France.; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, CP 31008, Pamplona, Navarra, Spain.; Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, CP 31008, Pamplona, Navarra, Spain.; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France; INSERM, UMR 1248, University of Limoges, France.; University of Dundee, School of Life Sciences, Division of Biological Chemistry and Drug Discovery, Dow Street, Dundee DD1 5EH, Scotland, United Kingdom.; University of Dundee, School of Life Sciences, Division of Biological Chemistry and Drug Discovery, Dow Street, Dundee DD1 5EH, Scotland, United Kingdom.; Normandie Univ, UNICAEN, CERMN, 14000, Caen, France.; Normandie Univ, UNICAEN, CERMN, 14000, Caen, France.; Normandie Univ, UNICAEN, CERMN, 14000, Caen, France.; Institut M{\'e}diterran{\'e}en de Biodiversit{\'e}et D'Ecologie Marine et Continentale (IMBE), Aix-Marseille Universit{\'e}, UMR CNRS IRD Avignon Universit{\'e}, Campus Timone - Facult{\'e} de Pharmacie, 27 Boulevard Jean-Moulin, F13385, Marseille Cedex 05, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; Aix Marseille Univ, IHU M{\'e}diterran{\'e}e Infection, UMR VITROME - Tropical Eukaryotic Pathogens, 19-21 Boulevard Jean Moulin, 13005, Marseille, France.; Universit{\'e}de Limoges, UMR Inserm 1094, Neuro{\'e}pid{\'e}miologie Tropicale, Facult{\'e}de Pharmacie, 2 Rue Du Dr Marcland, 87025, Limoges, France.; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin, CS30064, 13385, Marseille Cedex 05, France.; LCC-CNRS Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France. Electronic address: pierre.verhaeghe@lcc-toulouse.fr.},
	author = {Fersing, Cyril and Boudot, Clotilde and Paoli-Lombardo, Romain and Primas, Nicolas and Pinault, Emilie and Hutter, S{\'e}bastien and Castera-Ducros, Caroline and Kabri, Youssef and Pedron, Julien and Bourgeade-Delmas, Sandra and Sournia-Saquet, Alix and Stigliani, Jean-Luc and Valentin, Alexis and Azqueta, Amaya and Muruzabal, Dami{\'a}n and Destere, Alexandre and Wyllie, Susan and Fairlamb, Alan H and Corvaisier, Sophie and Since, Marc and Malzert-Fr{\'e}on, Aur{\'e}lie and Di Giorgio, Carole and Rathelot, Pascal and Azas, Nadine and Courtioux, Bertrand and Vanelle, Patrice and Verhaeghe, Pierre},
	cois = {Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.},
	copyright = {Copyright {\copyright}2020 Elsevier Masson SAS. All rights reserved.},
	crdt = {2020/08/16 06:00},
	date = {2020 Nov 15},
	date-added = {2022-10-10 16:59:05 -0400},
	date-modified = {2022-10-10 17:00:21 -0400},
	dcom = {20210419},
	dep = {20200804},
	doi = {10.1016/j.ejmech.2020.112668},
	edat = {2020/08/17 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {Imidazo{$[$}1,2-a{$]$}pyridine; Kinetoplastids; Nitroaromatic; Nitroreductases; Redox potentials; SARs},
	language = {eng},
	lid = {S0223-5234(20)30640-1 {$[$}pii{$]$}; 10.1016/j.ejmech.2020.112668 {$[$}doi{$]$}},
	lr = {20210419},
	mh = {Animals; DNA Damage/drug effects; Drug Discovery; Hep G2 Cells; Humans; Imidazoles/*chemistry/metabolism/pharmacokinetics/*pharmacology; Inhibitory Concentration 50; Mice; Parasitic Sensitivity Tests; Pyridines/*chemistry/metabolism/pharmacokinetics/*pharmacology; Serum Albumin/metabolism; Structure-Activity Relationship; Trypanocidal Agents/*chemistry/metabolism/pharmacokinetics/*pharmacology; Trypanosoma brucei brucei/*drug effects},
	mhda = {2021/04/20 06:00},
	month = {Nov},
	oto = {NOTNLM},
	own = {NLM},
	pages = {112668},
	phst = {2020/05/28 00:00 {$[$}received{$]$}; 2020/07/13 00:00 {$[$}revised{$]$}; 2020/07/14 00:00 {$[$}accepted{$]$}; 2020/08/17 06:00 {$[$}pubmed{$]$}; 2021/04/20 06:00 {$[$}medline{$]$}; 2020/08/16 06:00 {$[$}entrez{$]$}},
	pii = {S0223-5234(20)30640-1},
	pl = {France},
	pmid = {32795774},
	pst = {ppublish},
	pt = {Journal Article},
	rn = {0 (Imidazoles); 0 (Pyridines); 0 (Serum Albumin); 0 (Trypanocidal Agents); 0 (imidazopyridine)},
	sb = {IM},
	status = {MEDLINE},
	title = {Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.},
	volume = {206},
	year = {2020},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2020.112668}}

@article{mustiere-2021-thienopyrimidinone-plasmodium,
	abstract = {Human malaria infection begins with a one-time asymptomatic liver stage followed by a cyclic symptomatic blood stage. For decades, the research for novel antimalarials focused on the high-throughput screening of molecules that only targeted the asexual blood stages. In a search for new effective compounds presenting a triple action against erythrocytic and liver stages in addition to the ability to block the transmission of the disease via the mosquito vector, 2-amino-thienopyrimidinone derivatives were synthesized and tested for their antimalarial activity. One molecule, named gamhepathiopine (denoted as "M1" herein), was active at submicromolar concentrations against both erythrocytic (50% effective concentration [EC(50)] = 0.045 μM) and liver (EC(50) = 0.45 μM) forms of Plasmodium falciparum. Furthermore, gamhepathiopine efficiently blocked the development of the sporogonic cycle in the mosquito vector by inhibiting the exflagellation step. Moreover, M1 was active against artemisinin-resistant forms (EC(50) = 0.227 μM), especially at the quiescent stage. Nevertheless, in mice, M1 showed modest activity due to its rapid metabolization by P450 cytochromes into inactive derivatives, calling for the development of new parent compounds with improved metabolic stability and longer half-lives. These results highlight the thienopyrimidinone scaffold as a novel antiplasmodial chemotype of great interest to search for new drug candidates displaying multistage activity and an original mechanism of action with the potential to be used in combination therapies for malaria elimination in the context of artemisinin resistance. IMPORTANCE This work reports a new chemical structure that (i) displays activity against the human malaria parasite Plasmodium falciparum at 3 stages of the parasitic cycle (blood stage, hepatic stage, and sexual stages), (ii) remains active against parasites that are resistant to the first-line treatment recommended by the World Health Organization (WHO) for the treatment of severe malaria (artemisinins), and (iii) reduces transmission of the parasite to the mosquito vector in a mouse model. This new molecule family could open the way to the conception of novel antimalarial drugs with an original multistage mechanism of action to fight against Plasmodium drug resistance and block interhuman transmission of malaria.},
	address = {Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; D{\'e}partement de Parasitologie-Mycologie, UFR des Sciences Pharmaceutiques et Biologiques, Universit{\'e} F{\'e}lix Houphou{\"e}t Boigny, Abidjan, C{\^o}te d'Ivoire.; Aix Marseille Universit{\'e}, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, Marseille, France.; Service Central de la Qualit{\'e}et de l'Information Pharmaceutiques, APHM, H{\^o}pital Conception, Marseille, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Institut Cochingrid.462098.1, Inserm U1016, CNRS UMR8104, Universit{\'e}de Paris, Paris, France.; Institut Cochingrid.462098.1, Inserm U1016, CNRS UMR8104, Universit{\'e}de Paris, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Immunology of Viral Infections and Autoimmune Diseases, INSERM U1184, CEA, Universit{\'e} Paris Sud 11, Fontenay-aux-Roses, France.; Immunology of Viral Infections and Autoimmune Diseases, INSERM U1184, CEA, Universit{\'e} Paris Sud 11, Fontenay-aux-Roses, France.; Aix Marseille Universit{\'e}, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, Marseille, France.; Aix Marseille Universit{\'e}, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, Marseille, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.; Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN), Normandie Universit{\'e}, UNICAEN, Caen, France.; Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN), Normandie Universit{\'e}, UNICAEN, Caen, France.; Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN), Normandie Universit{\'e}, UNICAEN, Caen, France.; Aix Marseille Universit{\'e}, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, Marseille, France.; Service Central de la Qualit{\'e}et de l'Information Pharmaceutiques, APHM, H{\^o}pital Conception, Marseille, France.; Aix Marseille Universit{\'e}, IRD, AP-HM, SSA, VITROME, Marseille, France.; Aix Marseille Universit{\'e}, IRD, AP-HM, SSA, VITROME, Marseille, France.; Immunology of Viral Infections and Autoimmune Diseases, INSERM U1184, CEA, Universit{\'e} Paris Sud 11, Fontenay-aux-Roses, France.; Immunology of Viral Infections and Autoimmune Diseases, INSERM U1184, CEA, Universit{\'e} Paris Sud 11, Fontenay-aux-Roses, France.; Aix Marseille Universit{\'e}, IRD, AP-HM, SSA, VITROME, Marseille, France.; Institut des Biomol{\'e}cules Max Mousseron, UMR 5247, CNRS, Universit{\'e}de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.; Institut des Biomol{\'e}cules Max Mousseron, UMR 5247, CNRS, Universit{\'e}de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.; Institut des Biomol{\'e}cules Max Mousseron, UMR 5247, CNRS, Universit{\'e}de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.; LCC-CNRS, Universit{\'e}de Toulouse, CNRS UPR 8241, UPS, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Toulouse, France.; LCC-CNRS, Universit{\'e}de Toulouse, CNRS UPR 8241, UPS, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Toulouse, France.; LCC-CNRS, Universit{\'e}de Toulouse, CNRS UPR 8241, UPS, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Universit{\'e}de Toulouse, CNRS, UPS, Toulouse, France.; New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Toulouse, France.; LCC-CNRS, Universit{\'e}de Toulouse, CNRS UPR 8241, UPS, Toulouse, France.; CHU de Toulouse, Service Pharmacie, Toulouse, France.; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Universit{\'e}, Paris, France.},
	auid = {ORCID: 0000-0003-0331-8850; ORCID: 0000-0003-1825-1054; ORCID: 0000-0003-0359-3959; ORCID: 0000-0002-9468-4823; ORCID: 0000-0003-0238-2447; ORCID: 0000-0002-8059-1810},
	author = {Bosson-Vanga, Henriette and Primas, Nicolas and Franetich, Jean-Fran{\c c}ois and Lavazec, Catherine and Gomez, Lina and Ashraf, Kutub and Tefit, Maurel and Soulard, Val{\'e}rie and Dereuddre-Bosquet, Nathalie and Le Grand, Roger and Donnette, M{\'e}lanie and Musti{\`e}re, Romain and Amanzougaghene, Nadia and Tajeri, Shahin and Suzanne, Peggy and Malzert-Fr{\'e}on, Aur{\'e}lie and Rault, Sylvain and Vanelle, Patrice and Hutter, S{\'e}bastien and Cohen, Anita and Snounou, Georges and Roques, Pierre and Azas, Nadine and Lagard{\`e}re, Prisca and Lisowski, Vincent and Masurier, Nicolas and Nguyen, Michel and Paloque, Lucie and Benoit-Vical, Fran{\c c}oise and Verhaeghe, Pierre and Mazier, Dominique},
	crdt = {2021/11/02 01:00},
	date = {2021 Oct 31},
	date-added = {2022-10-10 16:59:05 -0400},
	date-modified = {2022-10-10 16:59:46 -0400},
	dep = {20210929},
	doi = {10.1128/Spectrum.00274-21},
	edat = {2021/11/03 06:00},
	eissn = {2165-0497},
	issn = {2165-0497},
	jcr = {MICROBIOL SPECTR},
	jid = {101634614},
	journal = {Microbiol. Spectr.},
	jt = {Microbiology Spectrum},
	keywords = {*2-amino-6-phenyl-thienopyrimidin-4(3H)-one; *antimalarials; *artemisinin resistance; *multistage activity},
	language = {eng},
	lid = {10.1128/Spectrum.00274-21 {$[$}doi{$]$}; e00274-21},
	lr = {20211228},
	mhda = {2021/11/03 06:00},
	month = {Oct},
	number = {2},
	oto = {NOTNLM},
	own = {NLM},
	pages = {e0027421},
	phst = {2021/11/02 01:00 {$[$}entrez{$]$}; 2021/11/03 06:00 {$[$}pubmed{$]$}; 2021/11/03 06:00 {$[$}medline{$]$}},
	pii = {00274-21; spectrum.00274-21},
	pmc = {PMC8557901},
	pmid = {34724729},
	pst = {ppublish},
	pt = {Journal Article; Research Support, Non-U.S. Gov't},
	sb = {IM},
	status = {In-Process},
	title = {A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.},
	volume = {9},
	year = {2021},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1128/Spectrum.00274-21}}

@article{primas-2014-imidazole-tdae,
	abstract = {{We describe herein the preparation of 4-{[}4-(chloromethyl)
   styryl]-1,2-dimethyl-5-nitro-1H-imidazole via a Stille cross-coupling
   reaction. After determining the best reaction conditions, we
   investigated the reactivity of this activated chloromethyl compound in a
   TDAE {[}tetrakis(dimethylamino) ethylene] strategy toward 10 various
   electrophiles, obtaining
   4-(4-substituted)styryl-1,2-dimethyl-5-nitro-1H-imidazoles in moderate
   to good yields.}},
	address = {RUDIGERSTR 14, D-70469 STUTTGART, GERMANY},
	affiliation = {Vanelle, P (Corresponding Author), Aix Marseille Univ, Inst Chim Radicalaire, UMR CNRS 7273, Lab Pharmacochim Radicalaire,Fac Pharm, 27 Blvd Jean Moulin CS 30064, F-13385 Marseille 05, France. Primas, Nicolas; Neilde, Kevin; Kabri, Youssef; Crozet, Maxime D.; Terme, Thierry; Vanelle, Patrice, Aix Marseille Univ, Inst Chim Radicalaire, UMR CNRS 7273, Lab Pharmacochim Radicalaire,Fac Pharm, F-13385 Marseille 05, France.},
	author = {Primas, Nicolas and Neilde, Kevin and Kabri, Youssef and Crozet, Maxime D. and Terme, Thierry and Vanelle, Patrice},
	author-email = {patrice.vanelle@univ-amu.fr},
	da = {2022-01-10},
	date-added = {2022-10-10 16:58:18 -0400},
	date-modified = {2022-10-10 16:58:50 -0400},
	doc-delivery-number = {AI4LY},
	doi = {10.1055/s-0033-1338572},
	eissn = {1437-210X},
	funding-acknowledgement = {CNRS Centre National de la Recherche Scientifique (CNRS) European Commission; Aix-Marseille University},
	funding-text = {This work was supported by the CNRS and Aix-Marseille University. The authors thank Michel Giorgi for the X-ray diffraction and structure analysis. We warmly thank V. Remusat for recording <SUP>1</SUP>H and <SUP>13</SUP>C NMR spectra and T. Schembri and D. Lafitte (Marseille Proteomique - PIT2) for HRMS spectra. We thank also O. Khoumeri for providing the N-tosylimine derivatives.},
	issn = {0039-7881},
	jcr = {SYNTHESIS-STUTTGART},
	journal = {Synthesis},
	journal-iso = {Synthesis},
	jt = {SYNTHESIS-STUTTGART},
	keywords = {nitroimidazole; Stille reaction; TDAE; carbanions; cross-coupling},
	keywords-plus = {CROSS-COUPLING REACTIONS; ORIGINAL SYNTHESIS; SRN1 REACTIONS; METRONIDAZOLE; DERIVATIVES; EFFICIENT; SERIES; TRICHOMONAS; FUNCTIONALIZATION; 5-NITROIMIDAZOLES},
	language = {English},
	month = {Feb},
	number = {3},
	number-of-cited-references = {52},
	orcid-numbers = {PRIMAS, Nicolas/0000-0002-6713-6039},
	pages = {348--356},
	publisher = {GEORG THIEME VERLAG KG},
	research-areas = {Chemistry},
	times-cited = {5},
	title = {Exploring the Synthesis and the Reactivity of 4-{[}4-(Chloromethyl) styryl]-1,2-dimethyl-5-nitro-1H-imidazole in TDAE Strategy},
	type = {Article},
	unique-id = {WOS:000336838100018},
	usage-count-last-180-days = {0},
	usage-count-since-2013 = {5},
	volume = {46},
	web-of-science-categories = {Chemistry, Organic},
	web-of-science-index = {Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)},
	year = {2014},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1055/s-0033-1338572%7D}}

@article{primas-2014-quinoxaline-antiplasmodial,
	abstract = {Thanks to a preliminary in vitro screening of several CCl3-substituted-nitrogen containing heterocycles belonging to our chemical library, the 2-trichloromethylquinoxaline scaffold appeared to be of potential interest for developing new antiplasmodial agents. Then, combining these experimental results to the antimalarial properties reported for various pyrrolo[1,2-a]quinoxaline derivatives, an original series of fifteen 7-substituted-4-trichoromethylpyrrolo[1,2-a]quinoxalines was synthesized in a 4 to 5 reaction steps pathway. All molecules were evaluated in vitro toward both their antiplasmodial activity on the K1 multi-resistant Plasmodium falciparum strain and their cytotoxicity on the HepG2 human cell line. Thus, 3 hit molecules were identified, displaying IC50 values in the micromolar range and low cytotoxicity values, reaching good selectivity indexes, in comparison with the reference drugs chloroquine and doxycycline. Structure-activity relationship studies showed that the pyrrolo[1,2-a]quinoxaline scaffold can support selective antiplasmodial activity when substituted at position 4 by a CCl3 group. However, substitution at position 7 of the same scaffold is neither beneficial for cytotoxicity nor favourable for the solubility in the biological media.},
	address = {Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Universit{\'e}de Caen Basse Normandie, Facult{\'e}des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN) - EA 4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France.; Universit{\'e}Paul Sabatier, Facult{\'e}des Sciences Pharmaceutiques - CNRS UPR 8241, Laboratoire de Chimie de Coordination, 205 Route de Narbonne, 31077 Toulouse Cedex 04, France.; Aix-Marseille Universit{\'e}, UMR MD 3, Infections Parasitaires, Transmission et Th{\'e}rapeutique, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Aix-Marseille Universit{\'e}, UMR MD 3, Infections Parasitaires, Transmission et Th{\'e}rapeutique, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Aix-Marseille Universit{\'e}, UMR MD 3, Infections Parasitaires, Transmission et Th{\'e}rapeutique, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Universit{\'e}de Caen Basse Normandie, Facult{\'e}des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN) - EA 4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France.; Universit{\'e}de Caen Basse Normandie, Facult{\'e}des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN) - EA 4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France.; Universit{\'e}de Caen Basse Normandie, Facult{\'e}des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN) - EA 4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France.; Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France.; Universit{\'e}de Caen Basse Normandie, Facult{\'e}des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le M{\'e}dicament de Normandie (CERMN) - EA 4258, FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France.; Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France. Electronic address: patrice.vanelle@univ-amu.fr.; Aix-Marseille Universit{\'e}, UMR MD 3, Infections Parasitaires, Transmission et Th{\'e}rapeutique, Facult{\'e} de Pharmacie, 27 Boulevard Jean Moulin - CS30064, 13385 Marseille Cedex 05, France. Electronic address: nadine.azas@univ-amu.fr.},
	author = {Primas, Nicolas and Suzanne, Peggy and Verhaeghe, Pierre and Hutter, S{\'e}bastien and Kieffer, Charline and Laget, Mich{\`e}le and Cohen, Anita and Broggi, Julie and Lancelot, Jean-Charles and Lesnard, Aur{\'e}lien and Dallemagne, Patrick and Rathelot, Pascal and Rault, Sylvain and Vanelle, Patrice and Azas, Nadine},
	copyright = {Copyright {\copyright}2014 Elsevier Masson SAS. All rights reserved.},
	crdt = {2014/06/20 06:00},
	date = {2014 Aug 18},
	date-added = {2022-10-10 16:58:18 -0400},
	date-modified = {2022-10-10 16:58:36 -0400},
	dcom = {20150402},
	dep = {20140610},
	doi = {10.1016/j.ejmech.2014.06.014},
	edat = {2014/06/20 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {In vitro HepG2 cytotoxicity; In vitro antiplasmodial activity; Plasmodium falciparum; Pyrrolo{$[$}1,2-a{$]$}quinoxaline; SARs; Trichloromethyl goup},
	language = {eng},
	lid = {S0223-5234(14)00533-9 {$[$}pii{$]$}; 10.1016/j.ejmech.2014.06.014 {$[$}doi{$]$}},
	lr = {20140728},
	mh = {Antimalarials/*chemical synthesis/chemistry/*pharmacology/toxicity; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Methylation; Plasmodium falciparum/*drug effects; Quinoxalines/*chemical synthesis/chemistry/*pharmacology/toxicity},
	mhda = {2015/04/04 06:00},
	month = {Aug},
	oto = {NOTNLM},
	own = {NLM},
	pages = {26--35},
	phst = {2014/04/24 00:00 {$[$}received{$]$}; 2014/05/26 00:00 {$[$}revised{$]$}; 2014/06/08 00:00 {$[$}accepted{$]$}; 2014/06/20 06:00 {$[$}entrez{$]$}; 2014/06/20 06:00 {$[$}pubmed{$]$}; 2015/04/04 06:00 {$[$}medline{$]$}},
	pii = {S0223-5234(14)00533-9},
	pl = {France},
	pmid = {24946216},
	pst = {ppublish},
	pt = {Journal Article; Research Support, Non-U.S. Gov't},
	rn = {0 (Antimalarials); 0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo{$[$}1,2-a{$]$}quinoxalines as new antiplasmodial agents.},
	volume = {83},
	year = {2014},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2014.06.014}}

@article{montana-2006-chloroketones-tdae,
	abstract = {{We report herein an original and rapid synthesis of new
   alpha-chloroketones in azaheterocyclic series based on TDAE strategy
   from the reaction between 2-(trichloromethyl)quinoxaline and aromatic
   aldehydes. This reactivity has been generalized to a quinolinic
   trichloride. (c) 2006 Elsevier Ltd. All rights reserved.}},
	address = {THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND},
	affiliation = {Vanelle, P (Corresponding Author), Univ Mediterranee, CNRS, Fac Pharm, UMR 6517,Lab Chim Organ Pharmaceut LCOP, 27 Bd Jean Moulin, F-13385 Marseille 05, France. Univ Mediterranee, CNRS, Fac Pharm, UMR 6517,Lab Chim Organ Pharmaceut LCOP, F-13385 Marseille 05, France.},
	author = {Montana, Marc and Terme, Thierry and Vanelle, Patrice},
	author-email = {patrice.vanelle@pharmacie.univ-mrs.fr},
	da = {2022-01-10},
	date-added = {2022-10-10 16:56:41 -0400},
	date-modified = {2022-10-10 16:58:03 -0400},
	doc-delivery-number = {079NB},
	doi = {10.1016/j.tetlet.2006.07.030},
	eissn = {1873-3581},
	issn = {0040-4039},
	jcr = {TETRAHEDRON LETT},
	journal = {Tetrahedron Lett.},
	journal-iso = {Tetrahedron Lett.},
	jt = {TETRAHEDRON LETTERS},
	keywords = {TDAE; 2-(trichloromethyl)quinoxaline; alpha-chloroketones; aromatic aldehydes},
	keywords-plus = {NUCLEOPHILIC TRIFLUOROMETHYLATION; CHLORINATION; TETRAKIS(DIMETHYLAMINO)ETHYLENE; ALDEHYDES; KETONES; CHLORIDE},
	language = {English},
	month = {SEP 11},
	number = {37},
	number-of-cited-references = {34},
	pages = {6573--6576},
	publisher = {PERGAMON-ELSEVIER SCIENCE LTD},
	research-areas = {Chemistry},
	times-cited = {39},
	title = {Original synthesis of alpha-chloroketones in azaheterocyclic series using TDAE approach},
	type = {Article},
	unique-id = {WOS:000240182400019},
	usage-count-last-180-days = {0},
	usage-count-since-2013 = {9},
	volume = {47},
	web-of-science-categories = {Chemistry, Organic},
	web-of-science-index = {Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)},
	year = {2006},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.tetlet.2006.07.030%7D}}

@article{montana-2014-quinoxaline-oxirane,
	abstract = {Neuroblastoma is an aggressive pediatric malignancy with significant chemotherapeutic resistance. In order to obtain new compounds active on neuroblastoma cell lines, we investigated the reactivity of carbanion formed via TDAE in quinoxaline series. The new synthesized compounds were tested for their anti-proliferative activity on two neuroblastoma cell lines, and seven oxirane derivatives obtained interesting activities.},
	address = {Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille 13385, France. marc.montana@univ-amu.fr.; Aix-Marseille Universit{\'e}, INSERM, CRO2, UMR{\_}S911, Marseille 13385, France. florian.correard@gmail.com.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille 13385, France. omar.khoumeri@univ-amu.fr.; Aix-Marseille Universit{\'e}, INSERM, CRO2, UMR{\_}S911, Marseille 13385, France. marie-anne.esteve@univ-amu.fr.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille 13385, France. thierry.terme@univ-amu.fr.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille 13385, France. patrice.vanelle@univ-amu.fr.},
	author = {Montana, Marc and Correard, Florian and Khoumeri, Omar and Esteve, Marie-Anne and Terme, Thierry and Vanelle, Patrice},
	cois = {The authors declare no conflict of interest.},
	crdt = {2014/09/20 06:00},
	date = {2014 Sep 18},
	date-added = {2022-10-10 16:56:41 -0400},
	date-modified = {2022-10-10 16:57:38 -0400},
	dcom = {20150601},
	dep = {20140918},
	doi = {10.3390/molecules190914987},
	edat = {2014/09/23 06:00},
	eissn = {1420-3049},
	issn = {1420-3049},
	jcr = {MOLECULES},
	jid = {100964009},
	journal = {Molecules},
	jt = {MOLECULES},
	language = {eng},
	lid = {10.3390/molecules190914987 {$[$}doi{$]$}},
	lr = {20211021},
	mh = {Cell Line, Tumor; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Neuroblastoma/*pathology; Quinoxalines/*chemical synthesis/pharmacology},
	mhda = {2015/06/02 06:00},
	month = {Sep},
	number = {9},
	own = {NLM},
	pages = {14987--14998},
	phst = {2014/07/25 00:00 {$[$}received{$]$}; 2014/09/09 00:00 {$[$}revised{$]$}; 2014/09/11 00:00 {$[$}accepted{$]$}; 2014/09/20 06:00 {$[$}entrez{$]$}; 2014/09/23 06:00 {$[$}pubmed{$]$}; 2015/06/02 06:00 {$[$}medline{$]$}},
	pii = {molecules190914987; molecules-19-14987},
	pmc = {PMC6271844},
	pmid = {25237753},
	pst = {epublish},
	pt = {Journal Article; Research Support, Non-U.S. Gov't},
	rn = {0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Synthesis of new quinoxalines containing an oxirane ring by the TDAE strategy and in vitro evaluation in neuroblastoma cell lines.},
	volume = {19},
	year = {2014},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.3390/molecules190914987}}

@article{montana-2019-quinoxaline-antitumoral,
	abstract = {Cancer is a leading cause of death and a major health problem worldwide. While many effective anticancer agents are available, the majority of drugs currently on the market are not specific, raising issues like the common side effects of chemotherapy. However, recent research hold promise for the development of more efficient and safer anticancer drugs. Quinoxaline and its derivatives are becoming recognized as a novel class of chemotherapeutic agents with activity against different tumors. The present review compiles and discusses studies concerning the therapeutic potential of the anticancer activity of quinoxaline derivatives, covering articles published between July 2013 and July 2018.},
	address = {Aix Marseille Univ, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France; Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), Oncopharma, H{\^o}pital Nord, Marseille, France.; Aix Marseille Univ, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France.; Aix Marseille Univ, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France.; Aix Marseille Univ, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France; Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), Service Central de la qualit{\'e} et de l'information pharmaceutiques (SCQIP), Marseille, France. Electronic address: patrice.vanelle@univ-amu.fr.},
	author = {Montana, M and Mathias, F and Terme, T and Vanelle, P},
	copyright = {Copyright {\copyright}2018 Elsevier Masson SAS. All rights reserved.},
	crdt = {2018/12/04 06:00},
	date = {2019 Feb 1},
	date-added = {2022-10-10 16:56:41 -0400},
	date-modified = {2022-10-10 16:57:24 -0400},
	dcom = {20190211},
	dep = {20181124},
	doi = {10.1016/j.ejmech.2018.11.059},
	edat = {2018/12/05 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {Anticancer; Biological applications; Chemistry; Kinase inhibitors; Quinoxaline; SAR},
	language = {eng},
	lid = {S0223-5234(18)31018-3 {$[$}pii{$]$}; 10.1016/j.ejmech.2018.11.059 {$[$}doi{$]$}},
	lr = {20190215},
	mh = {Antineoplastic Agents/*pharmacology; Humans; Neoplasms/*drug therapy; Quinoxalines/pharmacology/*therapeutic use},
	mhda = {2019/02/12 06:00},
	month = {Feb},
	oto = {NOTNLM},
	own = {NLM},
	pages = {136--147},
	phst = {2018/10/01 00:00 {$[$}received{$]$}; 2018/11/23 00:00 {$[$}revised{$]$}; 2018/11/23 00:00 {$[$}accepted{$]$}; 2018/12/05 06:00 {$[$}pubmed{$]$}; 2019/02/12 06:00 {$[$}medline{$]$}; 2018/12/04 06:00 {$[$}entrez{$]$}},
	pii = {S0223-5234(18)31018-3},
	pl = {France},
	pmid = {30503938},
	pst = {ppublish},
	pt = {Journal Article; Systematic Review},
	rn = {0 (Antineoplastic Agents); 0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Antitumoral activity of quinoxaline derivatives: A systematic review.},
	volume = {163},
	year = {2019},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2018.11.059}}

@article{montana-2020-quinoxaline-antiviral,
	abstract = {BACKGROUND: In recent decades, several viruses have jumped from animals to humans, triggering sizable outbreaks. The current unprecedent outbreak SARS-COV-2 is prompting a search for new cost-effective therapies to combat this deadly pathogen. Suitably functionalized polysubstituted quinoxalines show very interesting biological properties (antiviral, anticancer, and antileishmanial), ensuring them a bright future in medicinal chemistry. OBJECTIVES: Focusing on the promising development of new quinoxaline derivatives as antiviral drugs, this review forms part of our program on the anti-infectious activity of quinoxaline derivatives. METHODS: Study compiles and discusses recently published studies concerning the therapeutic potential of the antiviral activity of quinoxaline derivatives, covering the literature between 2010 and 2020. RESULTS: A final total of 20 studies included in this review. CONCLUSIONS: This review points to a growing interest in the development of compounds bearing a quinoxaline moiety for antiviral treatment. This promising moiety with different molecular targets warrants further investigation, which may well yield even more encouraging results regarding this scaffold.},
	address = {Laboratoire de Pharmaco-Chimie Radicalaire, Institut de Chimie Radicalaire ICR, Aix Marseille Univ, CNRS, UMR 7273, 13005 Marseille, France.; Oncopharma, H{\^o}pital Nord, Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), 13005 Marseille, France.; Laboratoire de Pharmaco-Chimie Radicalaire, Institut de Chimie Radicalaire ICR, Aix Marseille Univ, CNRS, UMR 7273, 13005 Marseille, France.; Laboratoire de Pharmaco-Chimie Radicalaire, Institut de Chimie Radicalaire ICR, Aix Marseille Univ, CNRS, UMR 7273, 13005 Marseille, France.; Laboratoire de Pharmaco-Chimie Radicalaire, Institut de Chimie Radicalaire ICR, Aix Marseille Univ, CNRS, UMR 7273, 13005 Marseille, France.; Service central de la qualit{\'e}et de l'information pharmaceutiques (SCQIP), Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), 13005 Marseille, France.},
	author = {Montana, Marc and Montero, Vincent and Khoumeri, Omar and Vanelle, Patrice},
	cois = {The authors declare no conflict of interest.},
	crdt = {2020/06/21 06:00},
	date = {2020 Jun 16},
	date-added = {2022-10-10 16:56:41 -0400},
	date-modified = {2022-10-10 16:57:09 -0400},
	dcom = {20200629},
	dep = {20200616},
	doi = {10.3390/molecules25122784},
	edat = {2020/06/21 06:00},
	eissn = {1420-3049},
	issn = {1420-3049},
	jcr = {MOLECULES},
	jid = {100964009},
	journal = {Molecules},
	jt = {MOLECULES},
	keywords = {SAR; antiviral; biological applications; chemistry; quinoxaline},
	language = {eng},
	lid = {10.3390/molecules25122784 {$[$}doi{$]$}; 2784},
	lr = {20201218},
	mh = {Antiviral Agents/*therapeutic use; Betacoronavirus/*drug effects; COVID-19; Coronavirus Infections/*drug therapy; DNA Viruses/drug effects; Humans; Pandemics; Pneumonia, Viral/*drug therapy; Quinoxalines/chemistry/*therapeutic use; SARS-CoV-2; Structure-Activity Relationship},
	mhda = {2020/07/01 06:00},
	month = {Jun},
	number = {12},
	oto = {NOTNLM},
	own = {NLM},
	pages = {2784},
	phst = {2020/05/26 00:00 {$[$}received{$]$}; 2020/06/04 00:00 {$[$}revised{$]$}; 2020/06/09 00:00 {$[$}accepted{$]$}; 2020/06/21 06:00 {$[$}entrez{$]$}; 2020/06/21 06:00 {$[$}pubmed{$]$}; 2020/07/01 06:00 {$[$}medline{$]$}},
	pii = {molecules25122784; molecules-25-02784},
	pmc = {PMC7356203},
	pmid = {32560203},
	pst = {epublish},
	pt = {Journal Article; Systematic Review},
	rn = {0 (Antiviral Agents); 0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.},
	volume = {25},
	year = {2020},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.3390/molecules25122784}}

@article{montana-2021-quinoxaline-mycobacterium,
	abstract = {Background. The past decades have seen numerous efforts to develop new antitubercular agents. Currently, the available regimens are lengthy, only partially effective, and associated with high rates of adverse events. The challenge is therefore to develop new agents with faster and more efficient action. The versatile quinoxaline ring possesses a broad spectrum of pharmacological activities, ensuring considerable attention to it in the field of medicinal chemistry. Objectives. In continuation of our program on the pharmacological activity of quinoxaline derivatives, this review focuses on potential antimycobacterial activity of recent quinoxaline derivatives and discusses their structure-activity relationship for designing new analogs with improved activity. Methods. The review compiles recent studies published between January 2011 and April 2021. Results. The final total of 23 studies were examined. Conclusions. Data from studies of quinoxaline and quinoxaline 1,4-di-N-oxide derivatives highlight that specific derivatives show encouraging perspectives in the treatment of Mycobacterium tuberculosis and the recent growing interest for these scaffolds. These interesting results warrant further investigation, which may allow identification of novel antitubercular candidates based on this scaffold.},
	address = {Aix Marseille Univ, CNRS, ICR, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e}de Pharmacie, 13005 Marseille, France.; Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), Oncopharma, 13015 Marseille, France.; Aix Marseille Univ, CNRS, ICR, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e}de Pharmacie, 13005 Marseille, France.; Aix Marseille Univ, CNRS, ICR, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e}de Pharmacie, 13005 Marseille, France.; Aix Marseille Univ, CNRS, ICR, Equipe Pharmaco-Chimie Radicalaire, Facult{\'e}de Pharmacie, 13005 Marseille, France.; Assistance Publique-H{\^o}pitaux de Marseille (AP-HM), Service Central de la Qualit{\'e}et de l'Information Pharmaceutiques (SCQIP), 13005 Marseille, France.},
	author = {Montana, Marc and Montero, Vincent and Khoumeri, Omar and Vanelle, Patrice},
	cois = {The authors declare no conflict of interest.},
	crdt = {2021/08/27 01:15},
	date = {2021 Aug 5},
	date-added = {2022-10-10 16:56:41 -0400},
	date-modified = {2022-10-10 16:56:57 -0400},
	dcom = {20210906},
	dep = {20210805},
	doi = {10.3390/molecules26164742},
	edat = {2021/08/28 06:00},
	eissn = {1420-3049},
	issn = {1420-3049},
	jcr = {MOLECULES},
	jid = {100964009},
	journal = {Molecules},
	jt = {MOLECULES},
	keywords = {Mycobacterium; SAR; biological applications; chemistry; quinoxaline; tuberculosis},
	language = {eng},
	lid = {10.3390/molecules26164742 {$[$}doi{$]$}; 4742},
	lr = {20210906},
	mh = {Anti-Bacterial Agents/*chemistry/*pharmacology; Mycobacterium tuberculosis/*drug effects; Quinoxalines/*chemistry/*pharmacology; Structure-Activity Relationship},
	mhda = {2021/09/07 06:00},
	month = {Aug},
	number = {16},
	oto = {NOTNLM},
	own = {NLM},
	pages = {4742},
	phst = {2021/06/11 00:00 {$[$}received{$]$}; 2021/07/16 00:00 {$[$}revised{$]$}; 2021/08/03 00:00 {$[$}accepted{$]$}; 2021/08/27 01:15 {$[$}entrez{$]$}; 2021/08/28 06:00 {$[$}pubmed{$]$}; 2021/09/07 06:00 {$[$}medline{$]$}},
	pii = {molecules26164742; molecules-26-04742},
	pmc = {PMC8398470},
	pmid = {34443334},
	pst = {epublish},
	pt = {Journal Article; Review},
	rn = {0 (Anti-Bacterial Agents); 0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Quinoxaline Moiety: A Potential Scaffold against Mycobacterium tuberculosis.},
	volume = {26},
	year = {2021},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.3390/molecules26164742}}

@article{hajri-2016-quinoxaline-arylethynyl,
	abstract = {We report a novel series of quinoxaline derivatives from which agents with antiproliferative activity have been identified. Two ethyl 3-(arylethynyl)quinoxaline-2-carboxylates demonstrated substantial antiproliferative activity against both human non-small cell lung carcinoma (A549) and glioblastoma (U87-MG) cell lines. Pyrido[4,3-b]quinoxalin-1(2H)-ones demonstrated poor activity against A549 and U87-MG cell lines. Three of the derivatives in ethyl 3-(arylethynyl)quinoxaline-2-carboxylate series demonstrated substantial antiproliferative activity. The arylethynyl derivative 2a and 2d proved to be the most cytotoxic with an IC(50) value of 3.3 μM for both A549 and U87-MG cell lines.},
	address = {University of Carthage, Faculty of Sciences of Bizerte, Laboratory of Physics of Lamellaires Materials and Hybrids Nanomaterials, Zarzouna 7021, Bizerte, Tunisia.; Aix-Marseille Universit{\'e}, INSERM, CRO2, UMR{\_}S911, 13385 Marseille, France; AP-HM, H{\^o}pital Timone, Pharmacie, 13005 Marseille, France.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France.; University of Carthage, Faculty of Sciences of Bizerte, Laboratory of Physics of Lamellaires Materials and Hybrids Nanomaterials, Zarzouna 7021, Bizerte, Tunisia.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France.; Aix-Marseille Universit{\'e}, CNRS, Institut de Chimie Radicalaire ICR, UMR 7273, Laboratoire de Pharmaco-Chimie Radicalaire, Marseille, France. Electronic address: patrice.vanelle@univ-amu.fr.},
	author = {Hajri, Majdi and Esteve, Marie-Anne and Khoumeri, Omar and Abderrahim, Raoudha and Terme, Thierry and Montana, Marc and Vanelle, Patrice},
	copyright = {Copyright {\copyright}2016 Elsevier Masson SAS. All rights reserved.},
	crdt = {2016/11/07 06:00},
	date = {2016 Nov 29},
	date-added = {2022-10-10 16:53:36 -0400},
	date-modified = {2022-10-10 16:53:52 -0400},
	dcom = {20170228},
	dep = {20161013},
	doi = {10.1016/j.ejmech.2016.10.025},
	edat = {2016/10/23 06:00},
	eissn = {1768-3254},
	issn = {0223-5234},
	jcr = {EUR J MED CHEM},
	jid = {0420510},
	journal = {Eur. J. Med. Chem.},
	jt = {EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY},
	keywords = {Antitumor activity; Organic chemistry; Quinoxaline; SAR},
	language = {eng},
	lid = {S0223-5234(16)30884-4 {$[$}pii{$]$}; 10.1016/j.ejmech.2016.10.025 {$[$}doi{$]$}},
	lr = {20170922},
	mh = {Antineoplastic Agents/*chemical synthesis/chemistry/*pharmacology; Carboxylic Acids/*chemistry; Cell Line, Tumor; Cell Proliferation/drug effects; Chemistry Techniques, Synthetic; *Drug Design; Humans; Quinoxalines/*chemical synthesis/chemistry/*pharmacology},
	mhda = {2017/03/01 06:00},
	month = {Nov},
	oto = {NOTNLM},
	own = {NLM},
	pages = {959--966},
	phst = {2016/06/01 00:00 {$[$}received{$]$}; 2016/10/10 00:00 {$[$}revised{$]$}; 2016/10/12 00:00 {$[$}accepted{$]$}; 2016/11/07 06:00 {$[$}entrez{$]$}; 2016/10/23 06:00 {$[$}pubmed{$]$}; 2017/03/01 06:00 {$[$}medline{$]$}},
	pii = {S0223-5234(16)30884-4},
	pl = {France},
	pmid = {27770736},
	pst = {ppublish},
	pt = {Journal Article},
	rn = {0 (Antineoplastic Agents); 0 (Carboxylic Acids); 0 (Quinoxalines)},
	sb = {IM},
	status = {MEDLINE},
	title = {Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.},
	volume = {124},
	year = {2016},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1016/j.ejmech.2016.10.025}}

@article{broggi-2014-oed,
	abstract = {One-electron reduction is commonly used in organic chemistry for the formation of radicals by the stepwise transfer of one or two electrons from a donor to an organic substrate. Besides metallic reagents, single-electron reducers based on neutral organic molecules have emerged as an attractive novel source of reducing electrons. The past 20 years have seen the blossoming of a particular class of organic reducing agents, the electron-rich olefins, and their application in organic synthesis. This Review gives an overview of the different types of organic donors and their specific characteristics in organic transformations.},
	address = {Aix-Marseille Universit{\'e}, CNRS, ICR UMR 7273, Faculty of Pharmacy, 27 Bd Jean Moulin, 13385, Marseille (France). julie.broggi@univ-amu.fr.},
	author = {Broggi, Julie and Terme, Thierry and Vanelle, Patrice},
	copyright = {Copyright {\copyright}2014 WILEY-VCH Verlag GmbH \& Co. KGaA, Weinheim.},
	crdt = {2013/11/26 06:00},
	date = {2014 Jan 7},
	date-added = {2022-10-10 16:53:05 -0400},
	date-modified = {2022-10-10 16:53:13 -0400},
	dcom = {20141023},
	dep = {20131124},
	doi = {10.1002/anie.201209060},
	edat = {2013/11/26 06:00},
	eissn = {1521-3773},
	issn = {1433-7851},
	jcr = {ANGEW CHEM INT EDIT},
	jid = {0370543},
	journal = {Angew. Chem.-Int. Edit.},
	jt = {ANGEWANDTE CHEMIE-INTERNATIONAL EDITION},
	keywords = {electron transfer; electron-rich olefins; organic electron donors; reduction},
	language = {eng},
	lid = {10.1002/anie.201209060 {$[$}doi{$]$}},
	lr = {20161125},
	mh = {Alkenes/chemical synthesis/*chemistry; Aza Compounds/chemical synthesis/chemistry; Chemistry Techniques, Synthetic/*methods; *Electron Transport; Heterocyclic Compounds/chemical synthesis/chemistry; Hydrocarbons, Fluorinated/chemical synthesis/chemistry; Imidazolidines/chemical synthesis/chemistry; *Models, Chemical; Molecular Structure},
	mhda = {2014/10/24 06:00},
	month = {Jan},
	number = {2},
	oto = {NOTNLM},
	own = {NLM},
	pages = {384--413},
	phst = {2012/11/12 00:00 {$[$}received{$]$}; 2013/05/16 00:00 {$[$}revised{$]$}; 2013/11/26 06:00 {$[$}entrez{$]$}; 2013/11/26 06:00 {$[$}pubmed{$]$}; 2014/10/24 06:00 {$[$}medline{$]$}},
	pl = {Germany},
	pmid = {24273111},
	pst = {ppublish},
	pt = {Journal Article; Research Support, Non-U.S. Gov't; Review},
	rn = {0 (Alkenes); 0 (Aza Compounds); 0 (Heterocyclic Compounds); 0 (Hydrocarbons, Fluorinated); 0 (Imidazolidines); HY1EN16W9T (tetrathiafulvalene)},
	sb = {IM},
	status = {MEDLINE},
	title = {Organic electron donors as powerful single-electron reducing agents in organic synthesis.},
	volume = {53},
	year = {2014},
	bdsk-file-1 = {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},
	bdsk-url-1 = {https://doi.org/10.1002/anie.201209060}}


@article{montero-2022-synth-vitro,
  author		  = {Vincent Montero and Marc Montana and Omar Khoumeri and
                  Florian Correard and Marie-Anne Est{\`e}ve and Patrice
                  Vanelle},
  title			  = {Synthesis, in Vitro Antiproliferative Activity, and in
                  Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives},
  journal		  = {Pharmaceuticals},
  volume		  = 15,
  number		  = 7,
  pages			  = 781,
  year			  = 2022,
  doi			  = {10.3390/ph15070781},
  url			  = {http://dx.doi.org/10.3390/ph15070781},
  DATE_ADDED	  = {Tue Feb 7 01:53:41 2023},
}
